Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05361915
Title Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Sorrento Therapeutics, Inc.

prostate cancer


Abiraterone + Abivertinib

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.